These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9715793)
1. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass. Larivière R; Lebel M; Kingma I; Grose JH; Boucher D Am J Hypertens; 1998 Aug; 11(8 Pt 1):989-97. PubMed ID: 9715793 [TBL] [Abstract][Full Text] [Related]
2. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats. Dumont Y; D'Amours M; Lebel M; Larivière R J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857 [TBL] [Abstract][Full Text] [Related]
3. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass. Larivière R; D'Amours M; Lebel M; Kingma I; Grose JH; Caron L Kidney Blood Press Res; 1997; 20(6):372-80. PubMed ID: 9453448 [TBL] [Abstract][Full Text] [Related]
4. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II. D'Amours M; Lebel M; Grose JH; Larivière R Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660 [TBL] [Abstract][Full Text] [Related]
5. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats. Brochu E; Lacasse S; Moreau C; Lebel M; Kingma I; Grose JH; Larivière R Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266 [TBL] [Abstract][Full Text] [Related]
6. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats. Dumont Y; D'Amours M; Lebel M; Larivière R Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268 [TBL] [Abstract][Full Text] [Related]
7. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Lebel M; Rodrigue ME; Agharazii M; Larivière R Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776 [TBL] [Abstract][Full Text] [Related]
8. Renal angiotensin II receptor regulation in two-kidney, one clip hypertensive rats: effect of ACE inhibition. Amiri F; Garcia R Hypertension; 1997 Sep; 30(3 Pt 1):337-44. PubMed ID: 9314414 [TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR. Haddad G; Garcia R J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837 [TBL] [Abstract][Full Text] [Related]
10. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension. Racasan S; Hahnel B; van der Giezen DM; Blezer EL; Goldschmeding R; Braam B; Kriz W; Koomans HA; Joles JA Kidney Int; 2004 Feb; 65(2):575-81. PubMed ID: 14717927 [TBL] [Abstract][Full Text] [Related]
11. Renal angiotensin II receptors and protein kinase C in diabetic rats: effects of insulin and ACE inhibition. Amiri F; Garcia R Am J Physiol Renal Physiol; 2000 Apr; 278(4):F603-12. PubMed ID: 10751221 [TBL] [Abstract][Full Text] [Related]
12. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels. Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115 [TBL] [Abstract][Full Text] [Related]
13. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. Lavoie P; Robitaille G; Agharazii M; Ledbetter S; Lebel M; Larivière R J Hypertens; 2005 Oct; 23(10):1895-903. PubMed ID: 16148614 [TBL] [Abstract][Full Text] [Related]
14. Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes. Yousif MH; Dhaunsi GS; Makki BM; Qabazard BA; Akhtar S; Benter IF Pharmacol Res; 2012 Sep; 66(3):269-75. PubMed ID: 22580236 [TBL] [Abstract][Full Text] [Related]
15. Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats. Vaňourková Z; Kramer HJ; Husková Z; Cervenka L; Vaněčková I Physiol Res; 2010; 59(3):339-345. PubMed ID: 20666571 [TBL] [Abstract][Full Text] [Related]
16. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats. Gardiner SM; Kemp PA; March JE; Bennett T Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510 [TBL] [Abstract][Full Text] [Related]
17. Renal angiotensin II receptor regulation and renin-angiotensin system inhibition in one-kidney, one clip hypertensive rats. Amiri F; Haddad G; Garcia R J Hypertens; 1999 Feb; 17(2):279-86. PubMed ID: 10067798 [TBL] [Abstract][Full Text] [Related]
18. Effect of losartan on angiotensin II-mediated endothelin and prostanoid excretion in humans. Quest DW; Gopalakrishnan V; McNeill JR; Wilson TW Am J Hypertens; 2000 Dec; 13(12):1288-94. PubMed ID: 11130773 [TBL] [Abstract][Full Text] [Related]
19. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition. Qiu C; Baylis C Kidney Int; 1999 Jun; 55(6):2390-6. PubMed ID: 10354287 [TBL] [Abstract][Full Text] [Related]
20. Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations. Verhagen AM; Braam B; Boer P; Gröne HJ; Koomans HA; Joles JA Kidney Int; 1999 Jul; 56(1):222-31. PubMed ID: 10411696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]